您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Keap1-Nrf2-IN-11
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Keap1-Nrf2-IN-11
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Keap1-Nrf2-IN-11图片
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
Keap1-Nrf2-IN-11 是一种Keap1-Nrf2抑制剂,其KD2值为 0.21 nM。Keap1-Nrf2-IN-11 抑制 ROS 和 NO 的产生以及 TNF-α 的表达。Keap1-Nrf2-IN-11 通过增加 Nrf2 核易位来缓解炎症。Keap1-Nrf2-IN-11 可用于抗炎研究。
生物活性

Keap1-Nrf2-IN-11 (compound 6k) is aKeap1-Nrf2inhibitor withKD2value of 0.21 nM. Keap1-Nrf2-IN-11 inhibits the productions of ROS and NO and the expression of TNF-α. Keap1-Nrf2-IN-11 relieves inflammations by increasing the Nrf2 nuclear translocation. Keap1-Nrf2-IN-11 can be used for anti-inflammatory research[1].

体外研究
(In Vitro)

Keap1-Nrf2-IN-11 (compound 6k) (10 μΜ) suppresses the production of ROS and NO and inhibits the concentration of proinflammatory cytokine TNF-α in LPS-induced murine peritoneal macrophage model[1].

体内研究
(In Vivo)

Keap1-Nrf2-IN-11 (compound 6k) (5-10 mg/kg; i.p.; ALI mouse model) has anti-inflammatory activity in vivo[1].
Keap1-Nrf2-IN-11 (compound 6k) (5 mg/kg; i.v.; SD rats) has the half time (T1/2), the clearance rate (CL) and apparent distribution volume (V) were 4.31 h, 5.57 mL/min/kg and 959 L/kg, respectively[1].
Keap1-Nrf2-IN-11 (compound 6k) (5 mg/kg; i.p.; ALI mouse model) has the half time (T1/2), maximum plasma concentration (Cmax), area under curve (AUC) and oral bioavailability (F) were 10.92 h, 707 ng/mL, 3702 ngoh/mL and 19.86%, respectively[1].

Animal Model:ALI mouse model[1]
Dosage:5, 10 and 20 mg/kg
Administration:Intraperitoneal injection; 30 mins.
Result:Had lower TNF-α, IL-1β and IL-6 levels in BALF in a dose-dependent manner.
Animal Model:ALI mouse model[1]
Dosage:5, 10 and 20 mg/kg
Administration:Intraperitoneal injection; 30 mins.
Result:Induced the Nrf2 nuclear accumulation in lung tissue cells by decreasing the cytosolic Nrf2 and increasing the nuclear Nrf2 in a dose–response manner.
Animal Model:SD rats[1]
Dosage:5 and 20 mg/kg
Administration:Intraperitoneal injection and oral gavage
Result:1.19
Administrationi.g. (20 mg/kg)i.v. (5 mg/kg)
Tmax(h)1.380.72
Tmax(h)10.924.31
Cmax(ng/mL)707.622631.69
AUC0-24(ng·h/mL)3061.554561.21
AUC0-∞(ng·h/mL)CL (mL/min/kg)3702.224799.24
CL (L/h/kg)6503.055.57
V (L/kg)114127.5959.54
MRT0-24(h)6.714.64
MRT0-∞(h)13.975.94
F %19.86
分子量

765.90

Formula

C36H43N7O8S2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.